Loss of Rassf1a cooperates with ApcMin to accelerate intestinal tumourigenesis

Oncogene

Volumn 27, Issue 32, 2008, Pages 4503-4508

  Van Der Weyden, L ^a   Arends, M J ^b   Dovey, O M ^a   Harrison, H L ^a   Lefebvre, G ^a   Conte, N ^a   Gergely, F V ^c   Bradley, A ^a   Adams, D J ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Li Ka Shing Centre   (United Kingdom)

Author keywords

Adenocarcinoma; Adenoma; APC; RASSF; catenin

Indexed keywords

APC PROTEIN; BETA CATENIN; KI 67 ANTIGEN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE DELETION; GENE FUNCTION; GENE INACTIVATION; GENOMIC INSTABILITY; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; MICROTUBULE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMALL INTESTINE ADENOMA; SMALL INTESTINE TUMOR;

MUS;

EID: 47949090445     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.94     Document Type: Article

References (25)

1. Adams DJ, Dermitzakis ET, Cox T, Smith J, Davies R, Banerjee R et al. (2005). Complex haplotypes, copy number polymorphisms and coding variation in two recently divergent mouse strains. Nat Genet 37: 532-536.
2. Alberici P, de Pater E, Cardoso J, Bevelander M, Molenaar L, Jonkers J et al. (2007). Aneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and human. Am J Pathol 170: 377-387.
3. Carothers AM, Melstrom Jr KA, Mueller JD, Weyant MJ, Bertagnolli MM. (2001). Progressive changes in adherens junction structure during intestinaladenoma formation in Apc mutant mice. J Biol Chem 276: 39094-39102.
4. Chung YJ, Jonkers J, Kitson H, Fiegler H, Humphray S, Scott C et al. (2004). A whole-genome mouse BAC microarray with 1-Mb resolution for analysis of DNA copy number changes by array comparative genomic hybridization. Genome Res 14: 188-196.
5. Cunningham F, Rios D, Griffiths M, Smith J, Ning Z, Cox T et al. (2006). TranscriptSNPView: a genome-wide catalog of mouse coding variation. Nat Genet 38: 853.
6. Estrabaud E, Lassot I, Blot G, Le Rouzic E, Tanchou V, Quemeneur E et al. (2007). RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of beta-catenin by interacting with βTrCP. Cancer Res 67: 1054-1061.
7. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715.
8. Graubert TA, Cahan P, Edwin D, Selzer RR, Richmond TA, Eis PS et al. (2007). A high-resolution map of segmental DNA copy number variation in the mouse genome. PLoS Genet 3: e3.
9. Guo C, Tommasi S, Liu L, Yee JK, Dammann R, Pfeifer GP. (2007). RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr Biol 17: 700-705.
10. Hupé P, Stransky N, Thiery JP, Radvanyi F, Barillot E. (2004). Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 20: 3413-3422.
11. Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH. (2004). Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 84: 884-893.
12. Luongo C, Moser AR, Gledhill S, Dove WF. (1994). Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54: 5947-5952.
13. Moser AR, Pitot HC, Dove WF. (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324.
14. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A et al. (1991). Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669.
15. Oliveira C, Velho S, Domingo E, Preto A, Hofstra RM, Hamelin R et al. (2005). Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer. Oncogene 24: 7630-7634.
16. Reya T, Clevers H. (2005). Wnt signalling in stem cells and cancer. Nature 434: 843-850.
17. Smyth GK. (2005). Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (eds). Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer: New York. pp 397-420.
18. Song MS, Song SJ, Ayad NG, Chang JS, Lee JH, Hong HK et al. (2004). The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 6: 129-137.
19. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C et al. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC. Science 256: 668-670.
20. Taketo MM. (2004). Shutting down Wnt signal-activated cancer. Nat Genet 36: 320-322.
21. Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, Tsark WM et al. (2005). Tumor susceptibility of Rassf1a knockout mice. Cancer Res 65: 92-98.
22. van Amerongen R, Berns A. (2006). Knockout mouse models to study Wnt signal transduction . Trends Genet 22: 678-689.
23. van der Weyden L, Adams DJ. (2007). The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta 1776: 58-85.
24. van der Weyden L, Tachibana KK, Gonzalez MA, Adams DJ, Ng BL, Petty R et al. (2005). The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol 25: 8356-8367.
25. van Engeland M, Roemen G, Brink M, Pachen MM, Weijenberg MP, de Bruine AP et al. (2002). K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene 21: 3792-3795.